07:00 , Jul 1, 2013 |  BC Week In Review  |  Financial News

Aviir financial update

Aviir said it secured $10 million in the third tranche of a $30 million round. Existing investor Merck Global Health Innovation Fund led the round with participation from existing investors Partners & Partners; Bay City...
08:00 , Feb 18, 2013 |  BC Week In Review  |  Financial News

Aviir financial update

Aviir said it secured $10 million in the second tranche of a planned $30 million round. Existing investor Merck Global Health Innovation Fund led the round with participation from existing investors Bay City Capital; Abderdare...
08:00 , Dec 10, 2012 |  BC Week In Review  |  Clinical News

MIRISK VP Assessment diagnostic data

A U.S. validation trial of 1,084 blood samples from subjects who had no evidence of heart disease and who were followed for over 8 years showed that Aviir's MIRISK VP Assessment correctly identified significantly more...
07:00 , Sep 24, 2012 |  BC Week In Review  |  Financial News

Aviir financial update

Aviir secured $5 million in debt and a $3 million line of credit on receivables from Silicon Valley Bank. Aviir Inc. , Palo Alto, Calif.   Business: Diagnostic, Cardiovascular   Date announced: 9/19/12  ...
08:00 , Jan 2, 2012 |  BC Week In Review  |  Financial News

Aviir completes venture financing

Aviir Inc. , Palo Alto, Calif.   Business: Diagnostic, Cardiovascular   Date completed: 12/19/11   Type: Venture financing   Raised: $10 million   Investors: Merck Global Health Innovation Fund; Bay City Capital; Aberdare Ventures; New...